Generated by All in One SEO v4.8.9, this is an llms.txt file, used by LLMs to index the site.

# CARI Guidelines

## Sitemaps

- [XML Sitemap](https://www.cariguidelines.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Management of CKD for Māori in Aotearoa New Zealand guideline summary](https://www.cariguidelines.org/management-of-ckd-for-maori-in-aotearoa-new-zealand-guideline-summary/)

## Pages

- [Home](https://www.cariguidelines.org/) - CARI Guidelines Caring for Australian and New Zealanders with Kidney Impairment Get in TouchWELCOME CARI Guidelines is the Australia and New Zealand guideline developers in nephrology.CARI Guidelines develop guidelines focused on the clinical management of patients with chronic kidney disease, including patients on dialysis and transplant recipients.CARI Guidelines is an externally funded research program within
- [Kidney stones](https://www.cariguidelines.org/guidelines/kidney-stones/) - We gratefully acknowledge the Australian and New Zealand Society of Nephrology (ANZSN) for their generous support in funding the development of these guidelines. Scope of the Kidney stones guidelines GUIDELINES Date Diagnosis and risk factors of kidney stones (PDF) October 2025 Metabolic evaluation for prevention of kidney stones (PDF) October 2025 Acute pain management of
- [Nutrition therapy for the prevention of kidney stones](https://www.cariguidelines.org/nutrition-therapy-for-the-prevention-of-kidney-stones/) - Fluid intake Sodium restriction Calcium & oxalate intake Fruit, vegetable & non-animal protein Future research suggestions Date written: October 2025 Authors: CARI Guidelines Kidney Stones Guideline Working Group Scope of the guidelines These guidelines deal with nutrition-focused prevention of kidney stones in adults. Other clinical practice guidelines should guide nutrition-focused prevention of kidney stones in children.
- [Pharmacological Prevention of Kidney Stones](https://www.cariguidelines.org/pharmacological-prevention-of-kidney-stones/) - Potassium citrate Thiazide diuretics Xanthine oxidase inhibitors Cystinuria Hyperoxaluria Future research suggestions Date written: October 2025 Authors: CARI Kidney Stones Working Group Scope of the guidelines These guidelines deal with pharmacological prevention of kidney stones in adults. Other clinical practice guidelines should guide pharmacological prevention of kidney stones in children. Background The incidence and prevalence
- [Acute pain management of kidney stones](https://www.cariguidelines.org/stones-pain/) - First line therapy Second line therapy Future research suggestions Date written: October 2025 Authors: CARI Guidelines Kidney Stones Working Group Scope of the guidelines These guidelines deal with the management of acute pain from kidney stones in adults. Other clinical practice guidelines should guide management of acute pain management of kidney stones in children. Background Acute pain
- [Diagnosis and risk factors of kidney stones](https://www.cariguidelines.org/guidelines/kidney-stones/diagnosis-and-risk-factors-of-kidney-stones/) - Low-dose CT for kidney stones Ultrasound for kidney stones Risk factors for kidney stones Future research suggestions Date written: October 2025 Authors: CARI Guidelines Kidney Stones Working Group Scope of the guidelines These guidelines deal with the diagnosis of and risk factors for kidney stones in adults. Otherclinical practice guidelines should guide diagnosis of and
- [Metabolic evaluation for prevention of kidney stones](https://www.cariguidelines.org/guidelines/kidney-stones/metabolic-evaluation-stone-analysis/) - Stone Analysis Metabolic Evaluation Future Research Scope of the guidelines These guidelines deal with the metabolic evaluation of kidney stones in adults. Other clinical practice guidelines should guide metabolic evaluation of kidney stones in children. Background These guidelines deal with the metabolic evaluation of kidney stones in adults. Other clinical practice guidelines should guide metabolic
- [CARI Commentaries on international guidelines](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/) - Commentary Status CARI commentary on the KDIGO Clinical Practice Guideline for Glomerulonephritis 2013 CARI commentary on KDIGO Clinical Practice Guideline for Hepatitis C 2013 CARI commentary on the KDIGO Clinical Practice Guideline for lipid management in chronic kidney disease 2014 CARI commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in
- [CARI Commentary - KDIGO Glomerular Diseases Guidelines](https://www.cariguidelines.org/commentaries/cari-commentary-kdigo-gd-guidelines/)
- [Autosomal Dominant Polycystic Kidney Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 Autosomal dominant polycystic kidney disease Status Imaging Approaches for Diagnosis This article was published in Seminars in Nephrology, 35(6),
- [Kidney stones - Nutrition therapy PDF](https://www.cariguidelines.org/kidney-stones-nutrition-therapy/)
- [Kidney stones - Metabolic evaluation PDF](https://www.cariguidelines.org/kidney-stones-metabolic-evaluation/)
- [Kidney stones - Acute pain management PDF](https://www.cariguidelines.org/stones_pain/)
- [Kidney stones - Pharmacological management](https://www.cariguidelines.org/kidney-stones-pharmacological-management/)
- [Kidney stones - Clinical diagnosis PDF](https://www.cariguidelines.org/guidelines/kidney-stones/kidney-stones-clinical-diagnosis/)
- [Kidney stones consumer involvement workshop](https://www.cariguidelines.org/kidney-stones-consumer-involvement-workshop/)
- [Living Guidelines](https://www.cariguidelines.org/living-guidelines/) - Chronic kidney diseasePeritoneal dialysisHaemodialysisKidney transplantationChronic kidney disease (predialysis) Recommendations cover: Autosomal dominant polycystic kidney disease Tolvaptan in the management of ADPKD Fluid intake and ketogenic diets Cardiovascular disease management in chronic kidney disease Cholesterol-lowering therapy SGLT2 inhibitor GLP-1 agonists (in development) Urate-lowering therapy Peritoneal dialysis Recommendations cover: Haemodialysis Recommendations cover: Kidney transplantantation Recommendations cover: IV
- [IV Fluids in kidney transplantation summary](https://www.cariguidelines.org/4559-2/)
- [Appendix D - Kidney Stones - Summary of Findings tables](https://www.cariguidelines.org/appendix-d-kidney-stones-summary-of-findings-tables/)
- [Appendix C - Kidney Stones - Evidence tables](https://www.cariguidelines.org/appendix-c-kidney-stones-evidence-tables/)
- [Appendix B - Kidney stones - Search strategies](https://www.cariguidelines.org/appendix-b-kidney-stones-search-strategies/)
- [Appendix A - Kidney stones - Guideline development methods](https://www.cariguidelines.org/appendix-a-kidney-stones-guideline-development-methods/)
- [Projects](https://www.cariguidelines.org/projects/) - Projects
- [Publications](https://www.cariguidelines.org/projects/publications-about-kha-cari-guidelines/) - PUBLICATIONS Commentary on the 2021 update of the KDIGO clinical practice guideline for management of blood pressure in chronic kidney disease Emily J See, Vanessa Cullen; Caring for Australians and New Zealanders with Kidney Impairment (CARI) Guideline Group. Nephrology (Carlton). 2025 Jan;30(1):e14414. doi: 10.1111/nep.14414. [PubMed abstract] Kidney failure from kidney stones: an ANZDATA study Hicham
- [About](https://www.cariguidelines.org/about/) - About CARI Guidelines MISSION CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence CARI Guidelines Governance CARI Guidelines operates as an externally funded research program
- [Patients](https://www.cariguidelines.org/patients/) - PATIENTS Patient and caregiver involvement is fundamental to the development of CARI guidelines. CARI Guidelines engages patients throughout the guideline development process and is committed to producing guidelines that improve patient outcomes, including consumer versions of the guidelines. Are you interested in CARI Guidelines? Please provided your contact information so CARI Guidelines can contact you
- [Chronic Kidney Disease: Kidney Stones](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Care of Kidney Transplant Recipients](https://www.cariguidelines.org/guidelines/transplant/care-of-kidney-transplant-recipients/) - TRANSPLANT GUIDELINES TRANSPLANTATION GUIDELINESStatusCare of Kidney Transplant RecipientsJan 2012CMV DiseaseDec 2011Recipient Assessment for TransplantationMar 2013Evidence summary for kidney or kidney-pancreas transplant recipients TRANSPLANTATION GUIDELINESStatusKHA-CARI adaptation of the KDIGO Guideline for the Care of Kidney Transplant Recipients (Complete P1-215)Jan 2012Part1 pages 1-91Part 2 pages 92-215Jan 2012 GUIDELINE SUMMARIES KHA-CARI adaptation of the KDIGO Clinical Practice Guideline
- [Māori in Aotearoa New Zealand CKD Guidelines](https://www.cariguidelines.org/guidelines/maori-aotearoa-new-zealand-ckd-guidelines/) - AOTEAROA NEW ZEALAND GUIDELINES Status Full guideline – Clinical practice guidelines for management of chronic kidney disease for Māori in Aotearoa New Zealand February 2023 Executive summary – Clinical practice guidelines for management of chronic kidney disease for Māori in Aotearoa New Zealand February 2023 Guideline summary – New Zealand Medical Journal Infographic February 2023
- [Acute Kidney Injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/) - ACUTE KIDNEY DISEASE GUIDELINES Acute Kidney InjuryStatusKHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney InjurySection 1. Definition and classification of acute kidney injuryMay 2014Section 2. Treatment of acute kidney injuryMay 2014Section 3. Prevention of acute kidney injuryMay 2014Section 4. Contrast induced acute kidney injuryMay 2014Section 5.1 Dialysis interventions for the treatment of
- [CARI Commentary on KDIGO 2021 Blood Pressure Guidelines (PDF)](https://www.cariguidelines.org/cari-commentary-on-kdigo-2021-blood-pressure-guidelines-pdf/)
- [Intravenous fluids in kidney transplantation](https://www.cariguidelines.org/intravenous-fluids-in-kidney-transplantation/)
- [Prioritisation survey - evidence-based recommendations for kidney care](https://www.cariguidelines.org/prioritisation-survey-evidence-based-recommendations-for-kidney-care/) - Please complete our Round 3 Survey https://bit.ly/CARISurvey Prioritisation protocol available here Patient information form provided below View Fullscreen
- [CARI Prioritisation protocol](https://www.cariguidelines.org/cari-prioritisation-protocol-page/)
- [Dietary ADPKD guidelines](https://www.cariguidelines.org/dietary-adpkd-guidelines/)
- [SGLT2 inhibitors living guideline draft](https://www.cariguidelines.org/sglt2-inhibitors-living-guideline-draft/)
- [Living Evidence](https://www.cariguidelines.org/projects/current-guidelines/living-evidence/) - LIVING EVIDENCE CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness. CARI Guidelines is a member of the Living Evidence Collaboration. CARI guidelines
- [Current Guidelines in Development](https://www.cariguidelines.org/projects/current-guidelines/current-guidelines-in-development/) - CURRENT GUIDELINES IN DEVELOPMENT CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness. Kidney Stones Update Chairs: Dr Hicham Hassan, The University of
- [CARI Guidelines Research](https://www.cariguidelines.org/projects/current-guidelines/cari-guidelines-research/) - CARI GUIDELINES RESEARCH CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness. CARI undertakes research activities that focus on key areas relevant to
- [First Nations Australian Guidelines](https://www.cariguidelines.org/guidelines/management-of-chronic-kidney-disease-among-first-nations/) - Sorry, your browser doesn't support embedded videos. GUIDELINES Date Recommendations for culturally safe kidney care in First Nations Australians Online version November 2022 Guideline summaries Medical Journal of Australia summary Renal Society of Australasia summary Executive summary Main takeaways – Information sheet Main takeaways – Slides and infographics October 2023 November 2023 February 2023
- [Renal Society of Australasia First Nations Australians Guideline Summary](https://www.cariguidelines.org/renal-society-of-australasia-first-nations-australians-guideline-summary/)
- [Guideline Summary - Recommendations for culturally safe clinical kidney care for First Nations Australians](https://www.cariguidelines.org/guideline-summary-recommendations-for-culturally-safe-clinical-kidney-care-for-first-nations-australians/)
- [Management of cholesterol-lowering therapy for people with chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/medical-therapies-to-reduce-chronic-kidney-disease-progression-and-cardiovascular-risk-lipid-lowering-therapy/) - MOST UP TO DATE ONLINE VERSION AVAILABLE HERE
- [First Nations Australians Guidelines - Appendix A](https://www.cariguidelines.org/first-nations-australians-guidelines-appendix-a/) - Guideline Development Methodology
- [Living guidelines on pharmacological therapy for autosomal dominant polycystic kidney disease](https://www.cariguidelines.org/living-guideline-pharmacological-therapy-adpkd/) - Digital version available on MAGICapp (LINK)
- [CKD management for Māori in Aotearoa New Zealand](https://www.cariguidelines.org/aotearoa-new-zealand-full-guidelines/)
- [RECOMMENDATIONS FOR CULTURALLY SAFE AND CLINICAL KIDNEY CARE FOR FIRST NATIONS AUSTRALIANS](https://www.cariguidelines.org/first-nations-australian-guidelines/)
- [First Nations Australians Guidelines - Appendix D](https://www.cariguidelines.org/first-nations-australians-guidelines-appendix-d/) - Summary of findings tables
- [Main takeaways of First Nations Australian Guidelines](https://www.cariguidelines.org/main-takeaways-of-first-nations-australian-guidelines/)
- [Executive summary - First Nations Australians Guidelines](https://www.cariguidelines.org/fnaexecutivesummary/)
- [Consumer summary of First Nations Australian guidelines - Slides & Infographics](https://www.cariguidelines.org/consumer-summary-of-first-nations-australian-guidelines-slides/)
- [Consumer summary - First Nations Australians Guidelines](https://www.cariguidelines.org/fnaconsumersummary/)
- [Infographic - CKD management for Māori in Aotearoa New Zealand infographic](https://www.cariguidelines.org/aotearoa-new-zealand-infographic/)
- [Main takeaways of First Nations Australian Guidelines](https://www.cariguidelines.org/main-takeaways-of-first-nations-australian-guidelines-slides/)
- [Executive summary - CKD management for Māori in Aotearoa New Zealand](https://www.cariguidelines.org/executive-summary-ckd-management-for-maori-in-aotearoa-new-zealand/)
- [CKD management for Māori in Aotearoa New Zealand](https://www.cariguidelines.org/guidelines/maori-in-aotearoa-new-zealand-guidelines/)
- [CARI Commentary of 2020 KDOQI Nutrition in CKD Guidelines Update](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/cari-commentary-of-2020-kdoqi-nutrition-in-ckd-guidelines-update/)
- [Infection Control for Haemodialysis Units](https://www.cariguidelines.org/guidelines/dialysis/infection-control-for-haemodialysis-units/) - DIALYSIS GUIDELINES DIALYSIS GUIDELINESStatusBiochemical and Haematological TargetsJan 2012Jul 2013Dialysis AdequacyApr 2013Infection Control for Haemodialysis UnitsNov 2018Peritonitis Treatment and ProphylaxisJan 2014Vascular AccessJune 2012 Infection Control for Haemodialysis UnitsStatusInfection Control for Haemodialysis UnitsNov 2018Appendices to Infection Control for Haemodialysis UnitsNov 2018Infection control in haemodialysis units – a nursing summary GUIDELINE SUMMARIES Kidney Health Australia – Caring for
- [Infection control in haemodialysis units - a nursing summary](https://www.cariguidelines.org/guidelines/dialysis/infection-control-for-haemodialysis-units/nursing-summary/)
- [Early Chronic Kidney Disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 Early Chronic Kidney DiseaseStatusDiagnosis, classification and staging of chronic kidney diseaseMay 2013Education strategiesMay 2013Medical therapies to reduce chronic kidney
- [Methodological summary - urate-lowering therapy](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/methodological-summary-urate-lowering-therapy/) - View Fullscreen
- [First Nations Australians Guidelines - Appendix C](https://www.cariguidelines.org/first-nations-australians-guidelines-appendix-c/) - Evidence Tables
- [First Nations Australians Guidelines - Appendix B](https://www.cariguidelines.org/first-nations-australians-guidelines-appendix-b/) - Search strategies
- [CARI commentary on the KDIGO clinical practice guideline on the evaluation and care of living kidney donors](https://www.cariguidelines.org/commentaries/cari-commentary-on-the-kdigo-clinical-practice-guideline-on-the-evaluation-and-care-of-living-kidney-donors/)
- [Commentaries](https://www.cariguidelines.org/commentaries/)
- [Annual Report 2020 & 2021](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2020-2021/)
- [Annual Report 2018 & 2019](https://www.cariguidelines.org/projects/reports-forms/annual-reports/kha-cari-annual-report-2018-2019/)
- [Annual Report 2017](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2017/)
- [Annual Report 2016](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2016/)
- [Annual Report 2015](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2015/)
- [Annual Report 2014](https://www.cariguidelines.org/projects/reports-forms/annual-reports/cari-annual-report-2014/)
- [Annual Report 2013](https://www.cariguidelines.org/projects/reports-forms/annual-reports/cari-annual-report-2013/)
- [CARI commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/kha-cari-commentary-on-the-kdigo-clinical-practice-guideline-for-the-management-of-blood-pressure-in-chronic-kidney-disease/)
- [CARI commentary on the KDIGO Clinical Practice Guideline for lipid management in chronic kidney disease](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/kha-cari-commentary-on-the-kdigo-clinical-practice-guideline-for-lipid-management-in-chronic-kidney-disease/)
- [CARI commentary on the KDIGO Clinical Practice Guideline for Glomerulonephritis](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/kha-cari-commentary-on-the-kdigo-clinical-practice-guideline-for-glomerulonephritis/)
- [CARI commentary on KDIGO Clinical Practice Guideline for Hepatitis C](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/kha-cari-commentary-on-kdigo-clinical-practice-guideline-for-hepatitis-c/)
- [CARI commentary on International treatment guidelines for anaemia in chronic kidney disease](https://www.cariguidelines.org/commentaries/kha-cari-commentaries-on-kdigo-guidelines/kha-cari-commentary-on-international-treatment-guidelines-for-anaemia-in-chronic-kidney-disease/)
- [Diagnosis & Treatment of Urinary Tract Infection in Children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/diagnosis-treatment-of-urinary-tract-infection-in-children/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 DIAGNOSIS & TREATMENT OF UTI IN CHILDRENStatusAcute managementNov 2014DiagnosisNov 2014Management & investigation of recurrent UTI/VURNov 2014Radiological investigation following UTINov
- [Urate-lowering therapy in CKD - Infographic](https://www.cariguidelines.org/patients/kha-cari-patient-and-caregiver-guideline/urate-lowering-therapy-in-ckd-infographic/)
- [Urate-lowering therapy for people with chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/medical-therapies-to-reduce-chronic-kidney-disease-progression-and-cardiovascular-risk-uric-acid-lowering-agents/) - ONLINE VERSION ON MAGICapp AVAILABLE HERE INFOGRAPHIC AVAILABLE HERE
- [Kidney Biopsy](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 Kidney BiopsyStatusBiopsy information and education for patients and caregiversNov 2019Pre-biopsy medication: Antiplatelet and anticoagulant agentsNov 2019Pre-biopsy medication: Desmopressin acetateNov
- [Consumer Guidelines for Kidney Biopsy - Infographic](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/consumer-guidelines-for-kidney-biopsy-infographic/)
- [CARI Guidelines - Consumer guidelines](https://www.cariguidelines.org/consumer-guidelines/)
- [CARI Guidelines Word document Public comment](https://www.cariguidelines.org/cari-guidelines-word-document-public-comment/) - This is an embedded Microsoft Office document, powered by Office.
- [Kidney biopsy consumer guideline](https://www.cariguidelines.org/patients/kha-cari-patient-and-caregiver-guideline/kidney-biopsy-consumer-guideline/)
- [CARI Consumer Guidelines](https://www.cariguidelines.org/patients/kha-cari-patient-and-caregiver-guideline/)
- [Kidney biopsy consumer guideline - Infographic](https://www.cariguidelines.org/patients/kha-cari-patient-and-caregiver-guideline/kidney-biopsy-consumer-guideline-infographic/)
- [Kidney biopsy consumer guideline - 1 page summary](https://www.cariguidelines.org/patients/kha-cari-patient-and-caregiver-guideline/kidney-biopsy-consumer-guideline-1-page-summary/)
- [Autosomal dominant polycystic kidney disease consumer guideline](https://www.cariguidelines.org/patients/kha-cari-patient-and-caregiver-guideline/kha-cari-patient-and-caregiver-guideline-for-the-diagnosis-and-management-of-autosomal-dominant-polycystic-kidney-disease/)
- [Kidney biopsy 1-page consumer guideline](https://www.cariguidelines.org/kidney-biopsy-1-page-consumer-guideline/)
- [Kidney biopsy consumer infographic](https://www.cariguidelines.org/kidney-biopsy-consumer-infographic/)
- [Contact](https://www.cariguidelines.org/contact/) - Contact US Get in touch Please contact us for any further information on published and current guidelines, and ongoing projects. For further relevant guideline development forms please click here. × GENERAL ENQUIRIES +612 9845 1470 cari.guidelines@sydney.edu.au CARI Guidelines Office Centre for Kidney Research Locked Bag 4001 Westmead NSW 2145
- [Guideline Developers](https://www.cariguidelines.org/guideline-developers/)
- [Evidence summary for kidney or kidney-pancreas transplant recipients](https://www.cariguidelines.org/guidelines/transplant/3609-2/)
- [Transplant](https://www.cariguidelines.org/guidelines/transplant/) - TRANSPLANT GUIDELINES CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness. TRANSPLANTATION GUIDELINESStatusCare of Kidney Transplant RecipientsJan 2012CMV DiseaseDec 2011Recipient Assessment for TransplantationMar
- [Implementation](https://www.cariguidelines.org/projects/implementation/implementation/) - IMPLEMENTATION PROJECT An essential part of the guideline development process is the formulation of a dissemination and implementation strategy. Implementation CARI Guidelines staff has been and is continuing to research the best methods for clinical practice guidelines. Implementation projects are undertaken to assess both the impact of CARI Guidelines on clinical practice and the barriers
- [Test](https://www.cariguidelines.org/test/) - Australia Australia Australia Australia Australia Australia Australia Australia
- [Dialysis Adequacy](https://www.cariguidelines.org/guidelines/dialysis/dialysis-adequacy/) - DIALYSIS GUIDELINES DIALYSIS GUIDELINESStatusBiochemical and Haematological TargetsJan 2012Jul 2013Dialysis AdequacyApr 2013Infection Control for Haemodialysis UnitsNov 2018Peritonitis Treatment and ProphylaxisJan 2014Vascular AccessJune 2012 DIALYSIS ADEQUACY: HAEMODIALYSISStatusDialysis membranesApr 2013 GUIDELINE SUMMARIES KHA-CARI guideline: Dialysis adequacy (haemodialysis): Dialysis membranes. Kerr PG, Toussaint ND. Nephrology 2013; 18(7): 485-8.
- [Dialysis membranes](https://www.cariguidelines.org/guidelines/dialysis/dialysis-adequacy/dialysis-membrane/)
- [Relevant guideline development forms](https://www.cariguidelines.org/projects/reports-forms/forms/) - GUIDELINE DEVELOPMENT FORMS Relevant guideline development forms The following forms are available for online submission or in Word format for your convenience. The online & Word forms can also be accessed from within the KHA-CARI Guidelines Development Manual. Conflict of Interest form OnlineWord formatNew Guideline Proposal form Protected: Guideline Developers Peer Review form Word format
- [Other reports](https://www.cariguidelines.org/projects/reports-forms/other-reports/) - OTHER REPORTS Other Reports CARI Guidelines Review Kidney Health Australia (KHA) and the Australian and New Zealand Society of Nephrology (ANZSN) through the Dialysis, Nephrology and Transplant Committee (DNT) commissioned an independent external review of the KHA-CARI guideline process in 2014 and produced a report in March 2015. Please find below the final KHA-CARI external
- [Vascular Access](https://www.cariguidelines.org/projects/implementation/implementation-project/vascular-access/) - IMPLEMENTATION PROJECT An essential part of the guideline development process is the formulation of a dissemination and implementation strategy. Vascular Access The Vascular Access Implementation Project was initiated in 2007. This project aimed to implement two vascular access CARI Guidelines: Preparation and placement of vascular access Selection of type of access Summary of the project
- [Iron](https://www.cariguidelines.org/projects/implementation/implementation-project/iron/) - IMPLEMENTATION PROJECT An essential part of the guideline development process is the formulation of a dissemination and implementation strategy. Iron In 2004, the first stage of an Iron implementation project was commenced. This involved performing a clinical audit of six renal centres for their practices and procedures regarding iron levels for their patients and comparison
- [Preventing infection in peritoneal dialysis patients](https://www.cariguidelines.org/projects/implementation/implementation-project/preventing-infection-in-peritoneal-dialysis-patients/) - IMPLEMENTATION PROJECT An essential part of the guideline development process is the formulation of a dissemination and implementation strategy. Preventing infection in peritoneal dialysis patients The Peritoneal Dialysis (PD) implementation project commenced in August 2010 when a call for Expressions of Interest was sent out to ANZSN members. The first steering committee meeting was held
- [Research Priorities in Chronic Kidney Disease](https://www.cariguidelines.org/projects/reports-forms/research-priorities-in-chronic-kidney-disease/) - RESEARCH PRIORITIES Research Priorities in Chronic Kidney Disease A national workshop was convened on the 7th February 2014 at the Mercure Sydney Hotel to explore research priorities in chronic kidney disease. The report below summarises the list of the top 20 research questions that came out of the workshop. Exploring Research Priorities in Chronic Kidney
- [Annual reports](https://www.cariguidelines.org/projects/reports-forms/annual-reports/) - ANNUAL REPORTS Annual reportsAnnual Report 2004Annual Report 2005Annual Report 2006Annual Report 2007Annual Report 2008Annual Report 2009Annual Report 2011Annual Report 2012Annual Report 2013Annual Report 2014Annual Report 2015Annual Report 2016Annual Report 2017Annual Report 2018 & 2019Annual Report 2020 & 2021 Reports & Forms Annual reports Other reports Relevant guideline development forms Research Priorities in Chronic Kidney Disease
- [Chronic Kidney Disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/) - CHRONIC KIDNEY DISEASE GUIDELINES CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness. Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary
- [Dialysis](https://www.cariguidelines.org/guidelines/dialysis/) - DIALYSIS GUIDELINES CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence and effectiveness. DIALYSIS GUIDELINESStatusBiochemical and Haematological TargetsJan 2012Jul 2013Dialysis AdequacyApr 2013Infection Control for Haemodialysis
- [Archived Guidelines](https://www.cariguidelines.org/guidelines/archived-guidelines/) - ARCHIVED GUIDELINES Listed below are KHA-CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Peritonitis Treatment and Prophylaxis](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/) - DIALYSIS GUIDELINES DIALYSIS GUIDELINESStatusBiochemical and Haematological TargetsJan 2012Jul 2013Dialysis AdequacyApr 2013Infection Control for Haemodialysis UnitsNov 2018Peritonitis Treatment and ProphylaxisJan 2014Vascular AccessJune 2012 Peritonitis Treatment and ProphylaxisStatusThe influence of PD systems and solutions on the incidence of peritonitis and catheter-related infectionsFeb 2014Management of PD-associated peritonitis in adults and childrenFeb 2014Catheter removal, adjunct therapies and timing of
- [Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control in haemodialysis units](https://www.cariguidelines.org/guidelines/guideline-summaries/kidney-health-australia-caring-for-australasians-with-renal-impairment-guideline-recommendations-for-infection-control-in-haemodialysis-units/)
- [Biochemical and Haematological Targets](https://www.cariguidelines.org/guidelines/dialysis/biochemical-and-haematological-targets/) - DIALYSIS GUIDELINES DIALYSIS GUIDELINESStatusBiochemical and Haematological TargetsJan 2012Jul 2013Dialysis AdequacyApr 2013Infection Control for Haemodialysis UnitsNov 2018Peritonitis Treatment and ProphylaxisJan 2014Vascular AccessJune 2012 Biochemical and Haematological TargetsStatusMINERAL AND BONE DISORDER (MBD)HaemoglobinNov 2011IronJul 2013
- [KHA-CARI Guideline Recommendations for renal biopsy](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-recommendations-for-renal-biopsy/)
- [Recipient Assessment for Transplantation](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/) - TRANSPLANT GUIDELINES TRANSPLANTATION GUIDELINESStatusCare of Kidney Transplant RecipientsJan 2012CMV DiseaseDec 2011Recipient Assessment for TransplantationMar 2013Evidence summary for kidney or kidney-pancreas transplant recipients GUIDELINE SUMMARIES KHA-CARI Guideline: Recipient Assessment for Transplantation. Campbell S, Pilmore H, Gracey D, Mulley W, Russell C, McTaggart S. Nephrology 2013; 18(6): 455-62.
- [CMV Disease](https://www.cariguidelines.org/guidelines/transplant/cmv-disease/) - TRANSPLANT GUIDELINES TRANSPLANTATION GUIDELINESStatusCare of Kidney Transplant RecipientsJan 2012CMV DiseaseDec 2011Recipient Assessment for TransplantationMar 2013Evidence summary for kidney or kidney-pancreas transplant recipients GUIDELINE SUMMARIES KHA-CARI Guideline: cytomegalovirus disease and kidney transplantation. Pilmore H, Pussell B, Goodman D. Nephrology 2011; 16(8):683-7
- [Vascular Access](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/) - DIALYSIS GUIDELINES DIALYSIS GUIDELINESStatusBiochemical and Haematological TargetsJan 2012Jul 2013Dialysis AdequacyApr 2013Infection Control for Haemodialysis UnitsNov 2018Peritonitis Treatment and ProphylaxisJan 2014Vascular AccessJune 2012 VASCULAR ACCESSStatusInsertion of cathetersJune 2012Nursing care of central venous cathetersJune 2012Nursing care of arteriovenous fistula/arteriovenous graftJune 2012Pre-operative examination of the vessels – diagnostic evaluation prior to permanent access selectionJune 2012Preparation and placement of
- [Vitamin D, Calcimimetics and Phosphate Binders](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/vitamin-d-calcimimetics-and-phosphate-binders/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 VITAMIN D, CALCIMIMETICS & PHOSPHATE BINDERSStatusUse of phosphate binders in kidney diseaseApr 2006Vitamin D in dialysis patientsApr 2006Use of
- [Nutrition and Growth in Kidney Disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 NUTRITION & GROWTH IN KIDNEY DISEASEStatusAnaemia and growth in childrenDec 2005Bone disease and growth in childrenDec 2005Dialysis adequacy in
- [Cardiovascular Disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/cardiovascular-disease/) - CHRONIC KIDNEY DISEASE GUIDELINES Chronic Kidney Disease GuidelinesStatusCardiovascular DiseaseMay 2013Diagnosis & Treatment of Urinary Tract Infection in ChildrenNov 2014Early Chronic Kidney DiseaseKidney BiopsyDec 2019Nutrition and Growth in Kidney DiseaseDec 2005Vitamin D, Calcimimetics and Phosphate BindersApr 2006 CARDIOVASCULAR DISEASEStatusCardiovascular disease: revascularisationMay 2013Cardiovascular effects of blood pressure lowering in patients with CKDMay 2013Heart failureMay 2013Medical management of
- [Chronic Kidney Disease: Cardiovascular Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-cardiovascular-disease/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Evaluation of Renal Function](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-evaluation-of-renal-function/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Urine Protein as Diagnostic Test](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-urine-protein-as-diagnostic-test/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Nutrition and growth in kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Prevention of Progression of Kidney Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Transplantation: Living Kidney Donors](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Transplantation: Deceased Kidney Donor Suitability](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-deceased-kidney-donor-suitability/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Transplantation: CMV Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-cmv-disease/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Transplantation: Care of Kidney Transplant Recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Transplantation: Calcineurin Inhibitors in Renal Transplantation](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Dialysis: Vascular Access](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-vascular-access/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Dialysis: Peritonitis Treatment & Prophylaxis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Dialysis: Biochemical and Haematological targets](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-biochemical-and-haematological-targets/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Dialysis Adequacy: Peritoneal Dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-peritoneal-dialysis/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Dialysis Adequacy: Haemodialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Dialysis: Acceptance onto Dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Type 2 Diabetes: Kidney Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-type-2-diabetes-kidney-disease/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Renal Vasculitis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renal-vasculitis/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Chronic Kidney Disease: Renovascular Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renovascular-disease/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived. Archived GuidelinesChronic Kidney Disease: Kidney StonesChronic Kidney Disease: Renovascular DiseaseChronic Kidney Disease: Renal VasculitisChronic Kidney Disease: Type 2 Diabetes: Kidney DiseaseDialysis: Acceptance onto DialysisDialysis Adequacy: HaemodialysisDialysis Adequacy: Peritoneal DialysisDialysis: Biochemical and Haematological targetsDialysis: Peritonitis Treatment & ProphylaxisDialysis: Vascular AccessTransplantation: Calcineurin Inhibitors
- [Response to the Independent CARI Guidelines Review Panel Recommendations](https://www.cariguidelines.org/projects/reports-forms/other-reports/response-to-the-independent-kha-cari-guidelines-review-panel-recommendations/)
- [Report on the CARI Guidelines process](https://www.cariguidelines.org/projects/reports-forms/other-reports/report-on-the-kha-cari-guidelines-process/)
- [Evidence summary for kidney or kidney-pancreas transplant recipients](https://www.cariguidelines.org/projects/current-guidelines/current-guidelines-in-development/covid-19-guidelines/evidence-summary-for-kidney-or-kidney-pancreas-transplant-recipients/)
- [COVID 19 Guidelines](https://www.cariguidelines.org/projects/current-guidelines/current-guidelines-in-development/covid-19-guidelines/)
- [Consumer evidence summary for kidney and kidney-pancreas transplant recipients](https://www.cariguidelines.org/patients/covid-19-evidence-summary/consumer-evidence-summary-for-kidney-and-kidney-pancreas-transplant-recipients/)
- [Consumer evidence summary for kidney and kidney-pancreas transplant recipients - Infographic](https://www.cariguidelines.org/patients/covid-19-evidence-summary/consumer-evidence-summary-for-kidney-and-kidney-pancreas-transplant-recipients-infographic/)
- [COVID-19 Evidence summary](https://www.cariguidelines.org/patients/covid-19-evidence-summary/)
- [Antihypertensive therapy in diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/antihypertensive-therapy-in-diabetic-nephropathy/)
- [Treatment of peritoneal dialysis associated peritonitis in adults](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/treatment-of-peritoneal-dialysis-associated-peritonitis-in-adults/)
- [Type of peritoneal dialysis catheter](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/type-of-peritoneal-dialysis-catheter/)
- [Treatment of peritoneal dialysis associated fungal peritonitis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/treatment-of-peritoneal-dialysis-associated-fungal-peritonitis/)
- [Peritoneal dialysis catheter related infection](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/peritoneal-dialysis-catheter-related-infection/)
- [Peritoneal dialysis-associated peritonitis in children](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/peritoneal-dialysis-associated-peritonitis-in-children/)
- [Peritoneal dialysis systems and solutions](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/peritoneal-dialysis-systems-and-solutions/)
- [Indications for removal of peritoneal dialysis catheters](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/indications-for-removal-of-peritoneal-dialysis-catheters/)
- [Use of urokinase](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/use-of-urokinase/)
- [Indications for recommencement of peritoneal dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/indications-for-recommencement-of-peritoneal-dialysis/)
- [Exit site and tunnel infection-mupirocin](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/exit-site-and-tunnel-infection-mupirocin/)
- [Timing of commencement of dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/timing-of-commencement-of-dialysis/)
- [Technique of insertion of peritoneal dialysis catheter](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/technique-of-insertion-of-peritoneal-dialysis-catheter/)
- [Prophylactic antibiotics for insertion of peritoneal dialysis catheters](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-peritonitis-treatment-prophylaxis/prophylactic-antibiotics-for-insertion-of-peritoneal-dialysis-catheters/)
- [Diabetes mellitus](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/diabetes-mellitus/)
- [Exploring Research Priorities in Chronic Kidney Disease](https://www.cariguidelines.org/projects/reports-forms/research-priorities-in-chronic-kidney-disease/exploring-research-priorities-in-chronic-kidney-disease/)
- [Evidence Grading:Interpretation of grading guideline statements recommendations and suggestions](https://www.cariguidelines.org/projects/reports-forms/forms/evidence-gradinginterpretation-of-grading-guideline-statements-recommendations-and-suggestions/)
- [Paediatric recipients](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/paediatric-recipients/)
- [Obesity in renal transplantation](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/obesity-in-renal-transplantation/)
- [Malignancy](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/malignancy/)
- [HIV, HBV and HCV infection](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/hiv-hbv-and-hcv-infection/)
- [Cardiovascular disease](https://www.cariguidelines.org/guidelines/transplant/recipient-assessment-for-transplantation/cardiovascular-disease/)
- [Part 2 pages 92-215](https://www.cariguidelines.org/guidelines/transplant/care-of-kidney-transplant-recipients/part-2-pages-92-215/)
- [KHA-CARI adaptation of the KDIGO Guideline for the Care of Kidney Transplant Recipients (Complete P1-215)](https://www.cariguidelines.org/guidelines/transplant/care-of-kidney-transplant-recipients/kha-cari-adaptation-of-the-kdigo-guideline-for-the-care-of-kidney-transplant-recipients-complete/)
- [Timing of commencement of peritoneal dialysis following catheter insertion](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/timing-of-commencement-of-peritoneal-dialysis-following-catheter-insertion/)
- [Nursing care of arteriovenous fistula/arteriovenous graft](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/nursing-care-of-arteriovenous-fistula-arteriovenous-graft/)
- [Annual Report 2012](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2012/)
- [Annual Report 2011](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2011/)
- [Annual Report 2009](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2009/)
- [Annual Report 2008](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2008/)
- [Annual Report 2007](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2007/)
- [Annual Report 2006](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2006/)
- [Annual Report 2005](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2005/)
- [Annual Report 2004](https://www.cariguidelines.org/projects/reports-forms/annual-reports/annual-report-2004/)
- [KHA-CARI Guideline: Recipient Assessment for Transplantation](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-recipient-assessment-for-transplantation/)
- [KHA-CARI Guideline: cytomegalovirus disease and kidney transplantation](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-cytomegalovirus-disease-and-kidney-transplantation/)
- [KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-adaptation-of-the-kdigo-clinical-practice-guideline-for-the-care-of-kidney-transplant-recipients/)
- [KHA-CARI Guideline: Vascular access – central venous catheters, arteriovenous fistulae and arteriovenous grafts](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-vascular-access-central-venous-catheters-arteriovenous-fistulae-and-arteriovenous-grafts/)
- [KHA-CARI Guideline: peritonitis treatment and prophylaxis](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-peritonitis-treatment-and-prophylaxis/)
- [KHA-CARI guideline: Dialysis adequacy (haemodialysis): Dialysis membranes](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-dialysis-adequacy-haemodialysis-dialysis-membranes/)
- [KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-kha-cari-adaptation-of-the-kdigo-clinical-practice-guideline-for-acute-kidney-injury-3/)
- [KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-recommendations-for-the-diagnosis-and-management-of-autosomal-dominant-polycystic-kidney-disease/)
- [KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-early-chronic-kidney-disease-detection-prevention-and-management/)
- [Section 1. Definition and classification of acute kidney injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-1-definition-and-classification-of-acute-kidney-injury/)
- [Guideline title: Diagnosis and Treatment of Urinary Tract Infection in Children](https://www.cariguidelines.org/guidelines/guideline-summaries/guideline-title-diagnosis-and-treatment-of-urinary-tract-infection-in-children/)
- [Cardiovascular disease in patients with chronic kidney disease](https://www.cariguidelines.org/guidelines/guideline-summaries/cardiovascular-disease-in-patients-with-chronic-kidney-disease/)
- [KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury.](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-kha-cari-adaptation-of-the-kdigo-clinical-practice-guideline-for-acute-kidney-injury-2/)
- [KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury.](https://www.cariguidelines.org/guidelines/guideline-summaries/kha-cari-guideline-kha-cari-adaptation-of-the-kdigo-clinical-practice-guideline-for-acute-kidney-injury/)
- [Guideline Summaries](https://www.cariguidelines.org/guidelines/guideline-summaries/)
- [Treatment of vascular steal syndrome](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/treatment-of-vascular-steal-syndrome/)
- [Treatment of dialysis catheter infection](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/treatment-of-dialysis-catheter-infection/)
- [Treatment of the thrombosed AVF/AVG: surgical vs radiological therapy](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/treatment-of-the-thrombosed-avf-avg-surgical-vs-radiological-therapy/)
- [Selection of type of access](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/selection-of-type-of-access/)
- [Prevention of dialysis catheter infectionialysis catheter infection](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/prevention-of-dprevention-of-dialysis-catheter-infectionialysis-catheter-infection/)
- [Preparation and placement of vascular access](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/preparation-and-placement-of-vascular-access/)
- [Pre-operative examination of the vessels - diagnostic evaluation prior to permanent access selection](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/pre-operative-examination-of-the-vessels-diagnostic-evaluation-prior-to-permanent-access-selection/)
- [Nursing care of central venous catheters](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/nursing-care-of-central-venous-catheters/)
- [Insertion of catheters](https://www.cariguidelines.org/guidelines/dialysis/vascular-access/insertion-of-catheters/)
- [Diagnostic tests for cytomegalovirus in renal transplantation](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-cmv-disease/diagnostic-tests-for-cytomegalovirus-in-renal-transplantation/)
- [Part1 pages 1-91](https://www.cariguidelines.org/guidelines/transplant/care-of-kidney-transplant-recipients/part1-pages-1-91/)
- [Pharmacological Management](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/pharmacological-management/)
- [Diet and Lifestyle Management](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/diet-and-lifestyle-management/)
- [Monitoring Disease Progression](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/monitoring-disease-progression/)
- [Screening for Polycystic Kidney Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/screening-for-polycystic-kidney-disease/)
- [Genetic Testing for Diagnosis](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/genetic-testing-for-diagnosis/)
- [Psychosocial Care](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/psychosocial-care/)
- [Use of calcimimetic drugs](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/vitamin-d-calcimimetics-and-phosphate-binders/use-of-calcimimetic-drugs/)
- [Vitamin D in dialysis patients](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/vitamin-d-calcimimetics-and-phosphate-binders/vitamin-d-in-dialysis-patients/) - [PubMed Citation]
- [Management of Polycystic Liver Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/management-of-polycystic-liver-disease/)
- [Management of Intracranial Aneurysms](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/management-of-intracranial-aneurysms/)
- [Management of Chronic Pain](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/management-of-chronic-pain/)
- [Imaging Approaches for Diagnosis](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/imaging-approaches-for-diagnosis/)
- [Micronutrient intake in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/micronutrient-intake-in-children/)
- [Metabolic acidosis and growth in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/metabolic-acidosis-and-growth-in-children/)
- [Evaluation & management of nutrition in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/evaluation-management-of-nutrition-in-children/)
- [Energy intake in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/energy-intake-in-children/)
- [Dialysis adequacy in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/dialysis-adequacy-in-children/)
- [Bone disease and growth in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/bone-disease-and-growth-in-children/)
- [Anaemia and growth in children](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/nutrition-and-growth-in-kidney-disease/anaemia-and-growth-in-children/)
- [Biopsy bleeding management](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/biopsy-bleeding-management/)
- [Post-renal biopsy care](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/post-renal-biopsy-care/)
- [Positioning for renal biopsy](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/positioning-for-renal-biopsy/)
- [Renal biopsy: Imaging](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/renal-biopsy-imaging/)
- [Renal biopsy: Needles](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/renal-biopsy-needles/)
- [Pre-biopsy medication: Desmopressin acetate](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/pre-biopsy-medication-desmopressin-acetate/)
- [Pre-biopsy medication: Antiplatelet and anticoagulant agents](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/pre-biopsy-medication-antiplatelet-and-anticoagulant-agents/)
- [Biopsy information and education for patients and caregivers](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/kidney-biopsy/biopsy-information-and-education-for-patients-and-caregivers/)
- [When to refer for specialist renal care](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/when-to-refer-for-specialist-renal-care/)
- [Vitamin D therapy (supplementation) in early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/vitamin-d-therapy-supplementation-in-early-chronic-kidney-disease/)
- [Symptoms, natural history and outcomes of early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/symptoms-natural-history-and-outcomes-of-early-chronic-kidney-disease/)
- [Screening for early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/screening-for-early-chronic-kidney-disease/)
- [Risk factors for early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/risk-factors-for-early-chronic-kidney-disease/)
- [Pregnancy and early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/pregnancy-and-early-chronic-kidney-disease/)
- [Primary prevention of chronic kidney disease: modification of lifestyle factors](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/primary-prevention-of-chronic-kidney-disease-modification-of-lifestyle-factors/)
- [Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/primary-prevention-of-chronic-kidney-disease-managing-diabetes-mellitus-to-reduce-the-risk-of-progression-to-ckd/)
- [Primary prevention of chronic kidney disease: blood pressure targets](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/primary-prevention-of-chronic-kidney-disease-blood-pressure-targets/)
- [Multidisciplinary or multifaceted renal care in early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/multidisciplinary-or-multifaceted-renal-care-in-early-chronic-kidney-disease/)
- [Modification of lifestyle and nutrition interventions for management of early chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/modification-of-lifestyle-and-nutrition-interventions-for-management-of-early-chronic-kidney-disease/)
- [Medical therapies to reduce chronic kidney disease progression and cardiovascular risk: anti-platelet therapy](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/medical-therapies-to-reduce-chronic-kidney-disease-progression-and-cardiovascular-risk-anti-platelet-therapy/)
- [Medical therapies to reduce chronic kidney disease progression and cardiovascular risk: glycaemic control](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/medical-therapies-to-reduce-chronic-kidney-disease-progression-and-cardiovascular-risk-glycaemic-control/)
- [Medical therapies to reduce chronic kidney disease progression and cardiovascular risk: anti-hypertensive/anti-proteinuric agents](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/medical-therapies-to-reduce-chronic-kidney-disease-progression-and-cardiovascular-risk-anti-hypertensive-anti-proteinuric-agents/)
- [Education strategies](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/education-strategies/)
- [Radiological investigation following UTI](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/diagnosis-treatment-of-urinary-tract-infection-in-children/radiological-investigation-following-uti/)
- [Management & investigation of recurrent UTI/VUR](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/diagnosis-treatment-of-urinary-tract-infection-in-children/management-investigation-of-recurrent-uti-vur/)
- [Diagnosis](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/diagnosis-treatment-of-urinary-tract-infection-in-children/diagnosis/)
- [Acute management](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/diagnosis-treatment-of-urinary-tract-infection-in-children/acute-management/)
- [Medical management of coronary artery disease (excluding lipid-lowering therapy)](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/cardiovascular-disease/medical-management-of-coronary-artery-disease-excluding-lipid-lowering-therapy/)
- [Heart failure](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/cardiovascular-disease/heart-failure/)
- [Cardiovascular effects of blood pressure lowering in patients with CKD](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/cardiovascular-disease/cardiovascular-effects-of-blood-pressure-lowering-in-patients-with-ckd/)
- [Section 6. New non-dialytic treatments for acute kidney injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-6-new-non-dialytic-treatments-for-acute-kidney-injury/)
- [Section 5.2. Dialysis interventions for the treatment of acute kidney injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-5-2-dialysis-interventions-for-the-treatment-of-acute-kidney-injury/)
- [Section 5.1 Dialysis interventions for the treatment of acute kidney injury: Anticoagulation](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-5-1-dialysis-interventions-for-the-treatment-of-acute-kidney-injury-anticoagulation/)
- [Section 4. Contrast induced acute kidney injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-4-contrast-induced-acute-kidney-injury/)
- [Section 3. Prevention of acute kidney injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-3-prevention-of-acute-kidney-injury/)
- [Section 2. Treatment of acute kidney injury](https://www.cariguidelines.org/guidelines/acute-kidney-injury/section-2-treatment-of-acute-kidney-injury/)
- [Technique of insertion of peritoneal dialysis catheter](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/technique-of-insertion-of-peritoneal-dialysis-catheter/)
- [Prophylaxis for exit site/tunnel infections using mupirocin](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/prophylaxis-for-exit-site-tunnel-infections-using-mupirocin/)
- [PD catheter-related infection: exit site and tunnel](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/pd-catheter-related-infection-exit-site-and-tunnel/)
- [Catheter removal, adjunct therapies and timing of reinsertion of PD catheter after peritonitis](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/catheter-removal-adjunct-therapies-and-timing-of-reinsertion-of-pd-catheter-after-peritonitis/)
- [Infection Control for Haemodialysis Units](https://www.cariguidelines.org/guidelines/dialysis/infection-control-for-haemodialysis-units/infection-control-for-haemodialysis-units/)
- [Appendices to Infection Control for Haemodialysis Units](https://www.cariguidelines.org/guidelines/dialysis/infection-control-for-haemodialysis-units/appendices-to-infection-control-for-haemodialysis-units/)
- [Cardiovascular disease: revascularisation](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/cardiovascular-disease/cardiovascular-disease-revascularisation/)
- [Iron](https://www.cariguidelines.org/guidelines/dialysis/biochemical-and-haematological-targets/iron/)
- [Haemoglobin](https://www.cariguidelines.org/guidelines/dialysis/biochemical-and-haematological-targets/haemoglobin/)
- [Use of phosphate binders in kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/vitamin-d-calcimimetics-and-phosphate-binders/use-of-phosphate-binders-in-kidney-disease/)
- [Chronic Kidney Disease: Autosomal-dominant polycystic kidney disease (ADPKD)](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease/)
- [Non-heart beating donors](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-deceased-kidney-donor-suitability/non-heart-beating-donors/)
- [Donor sepsis](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-deceased-kidney-donor-suitability/donor-sepsis/)
- [Donor cancer](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-deceased-kidney-donor-suitability/donor-cancer/)
- [Donors with sub-optimal renal function/structure](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-deceased-kidney-donor-suitability/donors-with-sub-optimal-renal-function-structure/)
- [Treatment of cytomegalovirus disease in renal transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-cmv-disease/treatment-of-cytomegalovirus-disease-in-renal-transplant-recipients/)
- [Pre-emptive treatment of cytomegalovirus](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-cmv-disease/pre-emptive-treatment-of-cytomegalovirus/)
- [Prophylaxis for cytomegalovirus infection in patients following renal transplantation](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-cmv-disease/prophylaxis-for-cytomegalovirus-infection-in-patients-following-renal-transplantation/)
- [Protein requirement in adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/protein-requirement-in-adult-kidney-transplant-recipients/)
- [Pregnancy](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/pregnancy/)
- [Nutritional management of dyslipidaemia in adult kidney transplant recipient](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-management-of-dyslipidaemia-in-adult-kidney-transplant-recipient/)
- [Nutritional management of hypertension in adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-management-of-hypertension-in-adult-kidney-transplant-recipients/)
- [Nutritional management of overweight and obesity in adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-management-of-overweight-and-obesity-in-adult-kidney-transplant-recipients/)
- [Nutritional management of hypophosphataemia in adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-management-of-hypophosphataemia-in-adult-kidney-transplant-recipients/)
- [Nutritional interventions for the prevention of bone disease in kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-interventions-for-the-prevention-of-bone-disease-in-kidney-transplant-recipients/)
- [Nutritional management of anaemia in adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-management-of-anaemia-in-adult-kidney-transplant-recipients/)
- [Nutritional management of diabetes mellitus in adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/nutritional-management-of-diabetes-mellitus-in-adult-kidney-transplant-recipients/)
- [Food safety recommendations for adult kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-care-of-kidney-transplant-recipients/food-safety-recommendations-for-adult-kidney-transplant-recipients/)
- [Therapeutic drug monitoring](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/therapeutic-drug-monitoring/)
- [Nephrotoxicity and calcineurin inhibitors](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/nephrotoxicity-and-calcineurin-inhibitors/)
- [Choice of calcineurin inhibitors in adult renal transplantation: Effects on transplant outcomes](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/choice-of-calcineurin-inhibitors-in-adult-renal-transplantation-effects-on-transplant-outcomes/)
- [Calcineurin inhibitors in renal transplantation: Adverse effects](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/calcineurin-inhibitors-in-renal-transplantation-adverse-effects/)
- [Calcineurin inhibitors in paediatric renal transplantation](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/calcineurin-inhibitors-in-paediatric-renal-transplantation/)
- [The addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-calcineurin-inhibitors-in-renal-transplantation/the-addition-of-anti-cd25-antibody-induction-to-standard-immunosuppressive-therapy-for-kidney-transplant-recipients/)
- [Vascular access surveillance](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-vascular-access/vascular-access-surveillance/)
- [Pharmacological approaches to preventing vascular access failure](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-vascular-access/pharmacological-approaches-to-preventing-vascular-access-failure/)
- [Parathyroid hormone](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-biochemical-and-haematological-targets/parathyroid-hormone/)
- [Magnesium](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-biochemical-and-haematological-targets/magnesium/)
- [Phosphate](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-biochemical-and-haematological-targets/phosphate/)
- [Calcium x phosphate product](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-biochemical-and-haematological-targets/calcium-x-phosphate-product/)
- [Calcium](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-biochemical-and-haematological-targets/calcium/)
- [Peritoneal transport and ultrafiltration](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-peritoneal-dialysis/peritoneal-transport-and-ultrafiltration/)
- [Selection of patients for automated peritoneal dialysis versus CAPD](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-peritoneal-dialysis/selection-of-patients-for-automated-peritoneal-dialysis-versus-capd/)
- [Monitoring patients on peritoneal dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-peritoneal-dialysis/monitoring-patients-on-peritoneal-dialysis/)
- [Small solute clearance targets in peritoneal dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-peritoneal-dialysis/small-solute-clearance-targets-in-peritoneal-dialysis/)
- [Optimising small solute clearances in peritoneal dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-peritoneal-dialysis/optimising-small-solute-clearances-in-peritoneal-dialysis/)
- [Hemodialysis anticoagulation and adequacy](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/hemodialysis-anticoagulation-and-adequacy/)
- [Water quality for hemodialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/water-quality-for-hemodialysis/)
- [Duration and frequency of HD therapy](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/duration-and-frequency-of-hd-therapy/)
- [Dose of haemodialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/dose-of-haemodialysis/)
- [Blood urea sampling methods](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/blood-urea-sampling-methods/)
- [Dialysis membranes](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/dialysis-membranes/)
- [Acidosis: target bicarbonate levels](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-adequacy-haemodialysis/acidosis-target-bicarbonate-levels/)
- [Timing of referral of chronic kidney disease patients to nephrology services (adult)](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/timing-of-referral-of-chronic-kidney-disease-patients-to-nephrology-services-adult/)
- [Quality of life](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/quality-of-life/)
- [Predialysis education](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/predialysis-education/)
- [Peritoneal dialysis versus haemodialysis (adult)](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/peritoneal-dialysis-versus-haemodialysis-adult/)
- [Other criteria for starting dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/other-criteria-for-starting-dialysis/)
- [Mode of dialysis at initiation](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/mode-of-dialysis-at-initiation/)
- [Level of renal function at which to initiate dialysis](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/level-of-renal-function-at-which-to-initiate-dialysis/)
- [Ethical considerations](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/ethical-considerations/)
- [Diabetes](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/diabetes/)
- [Coronary artery](https://www.cariguidelines.org/guidelines/archived-guidelines/dialysis-acceptance-onto-dialysis/coronary-artery/)
- [Prevention & management of chronic kidney disease in type 2 diabetes](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-type-2-diabetes-kidney-disease/prevention-management-of-chronic-kidney-disease-in-type-2-diabetes/)
- [Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-type-2-diabetes-kidney-disease/cost-effectiveness-and-socioeconomic-implications-of-prevention-and-management-of-chronic-kidney-disease-in-type-2-diabetes/)
- [Assessment of kidney function in type 2 diabetes](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-type-2-diabetes-kidney-disease/assessment-of-kidney-function-in-type-2-diabetes/)
- [Renal transplantation](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renal-vasculitis/renal-transplantation/)
- [Induction and maintenance therapy in ANCA-associated systemic vasculitis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renal-vasculitis/induction-and-maintenance-therapy-in-anca-associated-systemic-vasculitis/)
- [ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renal-vasculitis/anca-serology-in-the-diagnosis-and-management-of-anca-associated-renal-vasculitis/)
- [Screening tests for diagnosis of renal artery stenosis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renovascular-disease/screening-tests-for-diagnosis-of-renal-artery-stenosis/)
- [Role of distal protection devices](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renovascular-disease/role-of-distal-protection-devices/)
- [Natural history and progression of atherosclerotic renal vascular stenosis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renovascular-disease/natural-history-and-progression-of-atherosclerotic-renal-vascular-stenosis/)
- [Inhibition of the renin-angiotensin system](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renovascular-disease/inhibition-of-the-renin-angiotensin-system/)
- [Endovascular treatment](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-renovascular-disease/endovascular-treatment/)
- [Uric acid stones](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/uric-acid-stones/)
- [Radiological diagnosis of kidney stones](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/radiological-diagnosis-of-kidney-stones/)
- [Prevention of recurrent calcium nephrolithiasis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/prevention-of-recurrent-calcium-nephrolithiasis/)
- [Metabolic evaluation](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/metabolic-evaluation/)
- [Kidney stones epidemiology](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/kidney-stones-epidemiology/)
- [Cystine stones](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/cystine-stones/)
- [Clinical diagnosis of kidney stones](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-kidney-stones/clinical-diagnosis-of-kidney-stones/)
- [Lipid lowering therapy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-cardiovascular-disease/lipid-lowering-therapy/)
- [Classification of chronic kidney disease based on evaluation of kidney function](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-evaluation-of-renal-function/classification-of-chronic-kidney-disease-based-on-evaluation-of-kidney-function/)
- [Direct measurement of glomerular filtration rate](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-evaluation-of-renal-function/direct-measurement-of-glomerular-filtration-rate/)
- [Use of cystatin C measurement in evaluating kidney function](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-evaluation-of-renal-function/use-of-cystatin-c-measurement-in-evaluating-kidney-function/)
- [Use of estimated glomerular filtration rate to assess level of kidney function](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-evaluation-of-renal-function/use-of-estimated-glomerular-filtration-rate-to-assess-level-of-kidney-function/)
- [Use of serum creatinine concentration to assess level of kidney function](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-evaluation-of-renal-function/use-of-serum-creatinine-concentration-to-assess-level-of-kidney-function/)
- [Monitoring proteinuria in patients with suspected or known renal disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-urine-protein-as-diagnostic-test/monitoring-proteinuria-in-patients-with-suspected-or-known-renal-disease/)
- [Evaluation of proteinuria in children](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-urine-protein-as-diagnostic-test/evaluation-of-proteinuria-in-children/)
- [Performance characteristics of tests used in the initial evaluation](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-urine-protein-as-diagnostic-test/performance-characteristics-of-tests-used-in-the-initial-evaluation/)
- [Testing for proteinuria](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-urine-protein-as-diagnostic-test/testing-for-proteinuria/)
- [Water/fluid in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/water-fluid-in-pre-dialysis-patients/)
- [Vitamins in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/vitamins-in-pre-dialysis-patients/)
- [Sodium in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/sodium-in-pre-dialysis-patients/)
- [Sodium chloride and water intake in children](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/sodium-chloride-and-water-intake-in-children/)
- [Protein intake in children](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/protein-intake-in-children/)
- [Protein in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/protein-in-pre-dialysis-patients/)
- [Potassium in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/potassium-in-pre-dialysis-patients/)
- [Minerals in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/minerals-in-pre-dialysis-patients/)
- [Lipids/fats in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/lipids-fats-in-pre-dialysis-patients/)
- [Energy intake in predialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/energy-intake-in-predialysis-patients/)
- [Complementary medicines in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/complementary-medicines-in-pre-dialysis-patients/)
- [Carbohydrates in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/carbohydrates-in-pre-dialysis-patients/)
- [Acidosis in pre-dialysis patients](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-nutrition-and-growth-in-kidney-disease/acidosis-in-pre-dialysis-patients/)
- [Weight reduction in obese patients with chronic kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/weight-reduction-in-obese-patients-with-chronic-kidney-disease/)
- [Uric acid](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/uric-acid/)
- [Treatment of secondary membranous nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/treatment-of-secondary-membranous-nephropathy/)
- [Specific management of IgA nephropathy: role of cyclosporin and other therapies](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/specific-management-of-iga-nephropathy-role-of-cyclosporin-and-other-therapies/)
- [Specific management of IgA nephropathy: role of tonsillectomy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/specific-management-of-iga-nephropathy-role-of-tonsillectomy/)
- [Specific management of IgA nephropathy: role of triple therapy and cytotoxictherapy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/specific-management-of-iga-nephropathy-role-of-triple-therapy-and-cytotoxictherapy/)
- [Specific management of IgA nephropathy: role of fish oil](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/specific-management-of-iga-nephropathy-role-of-fish-oil/)
- [Specific management of IgA nephropathy: role of steriod therapy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/specific-management-of-iga-nephropathy-role-of-steriod-therapy/)
- [Specific effects of calcium channel blockers in diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/specific-effects-of-calcium-channel-blockers-in-diabetic-nephropathy/)
- [Smoking and the progression of diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/smoking-and-the-progression-of-diabetic-nephropathy/)
- [Smoking](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/smoking/)
- [Renal artery stenosis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/renal-artery-stenosis/)
- [Regular and frequent follow-up of patients with pre-end-stage kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/regular-and-frequent-follow-up-of-patients-with-pre-end-stage-kidney-disease/)
- [Reflux nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/reflux-nephropathy/)
- [Reducing proteinuria](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/reducing-proteinuria/)
- [Protein restriction to prevent the progression of diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/protein-restriction-to-prevent-the-progression-of-diabetic-nephropathy/)
- [Pregnancy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/pregnancy/)
- [Pre-dialysis education for patients with chronic kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/pre-dialysis-education-for-patients-with-chronic-kidney-disease/)
- [Phosphate](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/phosphate/)
- [Other forms of dietary interventions](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/other-forms-of-dietary-interventions/)
- [Other agents](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/other-agents/)
- [Multifactorial therapy and the progression of diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/multifactorial-therapy-and-the-progression-of-diabetic-nephropathy/)
- [Membranous nephropathy: role of alkylating agents](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/membranous-nephropathy-role-of-alkylating-agents/)
- [Membranous nephropathy: use of other therapies](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/membranous-nephropathy-use-of-other-therapies/)
- [Membranous nephropathy: role of cyclosporin therapy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/membranous-nephropathy-role-of-cyclosporin-therapy/)
- [Membranous nephropathy: role of steroids](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/membranous-nephropathy-role-of-steroids/)
- [Lipids](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/lipids/)
- [Glucose control and progression of diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/glucose-control-and-progression-of-diabetic-nephropathy/)
- [Focal segmental glomerulosclerosis (FSGS): use of other therapies](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/focal-segmental-glomerulosclerosis-fsgs-use-of-other-therapies/)
- [Focal segmental glomerulosclerosis (FSGS): correction of secondary causes](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/focal-segmental-glomerulosclerosis-fsgs-correction-of-secondary-causes/)
- [Focal segmental glomerulosclerosis (FSGS): cytotoxic therapy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/focal-segmental-glomerulosclerosis-fsgs-cytotoxic-therapy/)
- [Focal segmental glomerulosclerosis (FSGS): use of cyclosporin A](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/focal-segmental-glomerulosclerosis-fsgs-use-of-cyclosporin-a/)
- [Focal segmental glomerulosclerosis (FSGS): treatment with steroids](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/focal-segmental-glomerulosclerosis-fsgs-treatment-with-steroids/)
- [Exercise](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/exercise/)
- [Erythropoietin](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/erythropoietin/)
- [Early referral of patients with pre-end-stage kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/early-referral-of-patients-with-pre-end-stage-kidney-disease/)
- [Early detection of patients with kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/early-detection-of-patients-with-kidney-disease/)
- [Dietary protein restriction](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/dietary-protein-restriction/)
- [Control of hypercholesterolaemia and progression of diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/control-of-hypercholesterolaemia-and-progression-of-diabetic-nephropathy/)
- [Blood pressure control: role of specific anti-hypertensives](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/blood-pressure-control-role-of-specific-anti-hypertensives/)
- [Blood pressure control: targets](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/blood-pressure-control-targets/)
- [Angiotensin II antagonist](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/angiotensin-ii-antagonist/)
- [Analgesic-associated kidney disease](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/analgesic-associated-kidney-disease/)
- [Acidosis](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/acidosis/)
- [ACE inhibitor and angiotensin II antagonist combination treatment](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/ace-inhibitor-and-angiotensin-ii-antagonist-combination-treatment/)
- [ACE inhibitor treatment in diabetic nephropathy](https://www.cariguidelines.org/guidelines/archived-guidelines/chronic-kidney-disease-prevention-of-progression-of-kidney-disease/ace-inhibitor-treatment-in-diabetic-nephropathy/)
- [Surgical techniques in living donor nephrectomy](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/surgical-techniques-in-living-donor-nephrectomy/)
- [Psychosocial care of living kidney donors](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/psychosocial-care-of-living-kidney-donors/)
- [Potential child-bearing donors](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/potential-child-bearing-donors/)
- [Justification for living donor kidney transplantation](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/justification-for-living-donor-kidney-transplantation/)
- [Donors at risk: impaired glucose tolerance](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donors-at-risk-impaired-glucose-tolerance/)
- [Donors at risk: obesity](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donors-at-risk-obesity/)
- [Donors at risk: hypertension](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donors-at-risk-hypertension/)
- [Donors at risk: haematuria](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donors-at-risk-haematuria/)
- [Donors at risk: proteinuria](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donors-at-risk-proteinuria/)
- [Donor-specific transfusions](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donor-specific-transfusions/)
- [Donor renal function](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/donor-renal-function/)
- [Assessment of donor kidney anatomy](https://www.cariguidelines.org/guidelines/archived-guidelines/transplantation-living-kidney-donors/assessment-of-donor-kidney-anatomy/)
- [Management of Renal Stone Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/management-of-renal-stone-disease/)
- [Management of End-Stage Kidney Disease](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/management-of-end-stage-kidney-disease/)
- [Genetics and Genetic Counseling](https://www.cariguidelines.org/guidelines/archived-guidelines/autosomal-dominant-polycystic-kidney-disease-2/genetics-and-genetic-counseling/)
- [Diagnosis, classification and staging of chronic kidney disease](https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/diagnosis-classification-and-staging-of-chronic-kidney-disease/)
- [Treatment of peritoneal dialysis–associated fungal peritonitis](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/treatment-of-peritoneal-dialysis-associated-fungal-peritonitis/)
- [Prophylactic antibiotics for insertion of peritoneal dialysis catheter](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/prophylactic-antibiotics-for-insertion-of-peritoneal-dialysis-catheter/)
- [Type of PD catheter](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/type-of-pd-catheter/)
- [Management of PD-associated peritonitis in adults and children](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/management-of-pd-associated-peritonitis-in-adults-and-children/)
- [The influence of PD systems and solutions on the incidence of peritonitis and catheter-related infections](https://www.cariguidelines.org/guidelines/dialysis/peritonitis-treatment-and-prophylaxis/the-influence-of-pd-systems-and-solutions-on-the-incidence-of-peritonitis-and-catheter-related-infections/)
- [Current Guidelines](https://www.cariguidelines.org/projects/current-guidelines/)
- [Guidelines](https://www.cariguidelines.org/guidelines/)
- [Implementation Project](https://www.cariguidelines.org/projects/implementation/implementation-project/)
- [Implementation (Placeholder)](https://www.cariguidelines.org/projects/implementation/)
- [Reports & Forms](https://www.cariguidelines.org/projects/reports-forms/)
- [Departments](https://www.cariguidelines.org/departments/) - Medical Departments Kind words can be short and easy to speak, but their echoes are truly endless. Make An AppointmentStriving To Cover All Your Medical Needs Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo admin2020-06-10T00:29:08+00:00 General Practice Gallery General Practice Expert Health
- [Articles](https://www.cariguidelines.org/articles/) - Health Articles Kind words can be short and easy to speak, but their echoes are truly endless Subscribe To Our News Feed Management of CKD for Māori in Aotearoa New Zealand guideline summary Read More Make An Appointment Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam. BOOK

## Portfolio

- [General Practice](https://www.cariguidelines.org/portfolio-items/general-practice/) - Expert Health Unit There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable. If you are going to use a passage of lorem ipsum you need to be sure there isn’t anything embarrassing hidden
- [Ultrasound Echocardiogram](https://www.cariguidelines.org/portfolio-items/ultrasound-echocardiogram/) - Expert Health Unit There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable. If you are going to use a passage of lorem ipsum you need to be sure there isn’t anything embarrassing hidden
- [Pre-natal Care](https://www.cariguidelines.org/portfolio-items/pre-natal-care/) - Expert Health Unit There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable. If you are going to use a passage of lorem ipsum you need to be sure there isn’t anything embarrassing hidden
- [Diabetes Care](https://www.cariguidelines.org/portfolio-items/diabetes-care/) - Expert Health Unit There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable. If you are going to use a passage of lorem ipsum you need to be sure there isn’t anything embarrassing hidden
- [Pediatrics](https://www.cariguidelines.org/portfolio-items/pediactrics/) - Expert Health Unit There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable. If you are going to use a passage of lorem ipsum you need to be sure there isn’t anything embarrassing hidden
- [Cardiology](https://www.cariguidelines.org/portfolio-items/cardiology/) - Expert Health Unit There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don’t look even slightly believable. If you are going to use a passage of lorem ipsum you need to be sure there isn’t anything embarrassing hidden

## Fusion Elements

- [Logo Slider](https://www.cariguidelines.org/fusion_element/logo-slider/)
- [Archived Guidelines Heading](https://www.cariguidelines.org/fusion_element/archived-guidelines-heading/) - ARCHIVED GUIDELINES Listed below are CARI Guidelines which are out-of-date and have been archived.
- [Indigenous guidelines](https://www.cariguidelines.org/fusion_element/indigenous-guidelines/)
- [New Zealand guidelines](https://www.cariguidelines.org/fusion_element/new-zealand-guidelines/) - AOTEAROA/NEW ZEALAND GUIDELINES Status Full guideline – Clinical practice guidelines for management of chronic kidney disease for Māori in Aotearoa/New Zealand February 2023 Executive summary – Clinical practice guidelines for management of chronic kidney disease for Māori in Aotearoa/New Zealand Under development Infographic Under development APPENDICES
- [implementation Project Heading](https://www.cariguidelines.org/fusion_element/implementation-project-heading/) - IMPLEMENTATION PROJECT An essential part of the guideline development process is the formulation of a dissemination and implementation strategy.
- [CKD Guidelines Home](https://www.cariguidelines.org/fusion_element/ckd-guidelines-home/)
- [ARCHIVED Subcategory](https://www.cariguidelines.org/fusion_element/archived-subcategory/)
- [Chronic Pagetitle](https://www.cariguidelines.org/fusion_element/chronic-pagetitle/)
- [Acute Kidney Injury Table](https://www.cariguidelines.org/fusion_element/acute-kidney-injury-table/)
- [Green Background - Pagetitle](https://www.cariguidelines.org/fusion_element/green-background-pagetitle/)
- [Archive 5050](https://www.cariguidelines.org/fusion_element/archive-5050/) - Transplantation: Living Kidney Donors Assessment of donor kidney anatomy Donor renal function Donor-specific transfusions Donors at risk: haematuria Donors at risk: hypertension Donors at risk: impaired glucose tolerance Donors at risk: obesity Donors at risk: proteinuria Justification for living donor kidney transplantation Potential child-bearing donors Psychosocial care of living kidney donors Surgical techniques in living
- [1/6 Empty Column](https://www.cariguidelines.org/fusion_element/1-6-empty-column/)
- [Side Menu](https://www.cariguidelines.org/fusion_element/side-menu/)
- [Guidelines - Pagetitle](https://www.cariguidelines.org/fusion_element/guidelines-pagetitle/)
- [Page Title on grey](https://www.cariguidelines.org/fusion_element/page-title-on-grey/)
- [Page Title](https://www.cariguidelines.org/fusion_element/page-title/)
- [Sub page list with archive text](https://www.cariguidelines.org/fusion_element/sub-page-list-with-archive-text/)
- [Sub Page list with summary hardcoded](https://www.cariguidelines.org/fusion_element/sub-page-list-with-summary-hardcoded/)
- [Headline Block](https://www.cariguidelines.org/fusion_element/headline-block/)
- [Project Item](https://www.cariguidelines.org/fusion_element/project-item/)
- [Contact](https://www.cariguidelines.org/fusion_element/contact/)
- [Guidelines Content Block](https://www.cariguidelines.org/fusion_element/guidelines-content-block/)
- [About - Health Values](https://www.cariguidelines.org/fusion_element/about-health-values/)
- [Home - Meet the Drs](https://www.cariguidelines.org/fusion_element/home-meet-the-drs/)
- [Homepage Banner](https://www.cariguidelines.org/fusion_element/homepage-banner/)

## Categories

- [Uncategorized](https://www.cariguidelines.org/category/uncategorized/)

## Portfolio Categories

- [Cardiology](https://www.cariguidelines.org/portfolio_category/cardiology/)
- [Care](https://www.cariguidelines.org/portfolio_category/care/)
- [General Practice](https://www.cariguidelines.org/portfolio_category/general-practice/)
- [Pediactrics](https://www.cariguidelines.org/portfolio_category/pediactrics/)
- [Sports](https://www.cariguidelines.org/portfolio_category/sports/)
- [Ultrasound](https://www.cariguidelines.org/portfolio_category/ultrasound/)